Eli Lilly says next-generation weight loss drug clears crucial obesity trial
RSS SUMMARY · AGGREGATED FROM CNBC
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Finland’s president says EU should expand to 40 states — including Canada
CNBC·2h ago·3 min read
Health
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
CNBC·1h ago·3 min read
US
Amazon engineers in Seattle slam employer for building AI data centers while laying off 30,000 staffers
CNBC·7h ago·3 min read
US
Elon Musk’s net worth poised to sail past $1 trillion in SpaceX IPO
CNBC·8h ago·3 min read
Related
On this beat
Business
Swiss Inflation Holds Steady Ahead of SNB Meeting
TWSJ·45m ago·3 min read
Business
Costco and UPS issue bold message on tariff refunds
THE STREET·1h ago·3 min read
Business
Partners Group hit by surge in withdrawal requests at second major fund
FT·1h ago·3 min read
Business
Remy Cointreau Expects Return to Sustainable Organic Sales Growth in Year Ahead
TWSJ·1h ago·3 min read